Omeros Corporation

Ticker OMER

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Seattle, Washington

Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets Omidria for use during cataract surgery or intraocular lens, or replacement surgery.

Visit website

REPORT RATINGS

4.8 / 5.0 (127)

Omeros Corporation reports have an aggregate usefulness score of 4.8 based on 127 reviews.

Omeros Corporation

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Omeros Corporation does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.